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Abstract
Background: Quality of life is an important concept which is subjective and personal; what is an
acceptable quality of life to one may be 'worse than death' to another. The objective of this study
was to develop and validate a questionnaire to assess relatives' perceptions and attitudes towards
their terminal stage cancer patients' management (information disclosure, treatment choice,
hospitalization and support-communication and care) including aspects regarding end-of-life and
quality-of-life decisions.
Methods: The final study consisted of 146 relatives of advanced terminal stage cancer patients
receiving palliation, attending a Pain Relief and Palliative Care Unit. The questionnaire incorporated
6 multi-item and 7 single-item scales, and was developed following a systematic review of measures
appropriate for use in palliative care settings.
Results:  Following analysis of the 25-item scale, the questionnaire has been validated as a
shortened 21-item scale consisting of 5 multi-item and 5 single-item scales. Factor analysis was
based upon information disclosure, hospitalization, and support-communication demonstrating
Cronbach's alpha coefficients of 0.66, 0.5 and 0.70 respectively. Average item totals and inter-item
scale correlations were between 0.62–0.70, with convergent validity correlations between 0.60–
0.86. The questionnaire was well accepted by all subjects with an 8–10 minute completion time.
Conclusion: The shortened 21-item self-assessment questionnaire may provide acceptable and
valid assessment of caregiver(s)/Greek cancer patients' relatives perceptions on palliative care.
Background
Quality of life is an important clinical outcome in assess-
ing the efficacy of health care. It is a concept that includes
many subjective elements: physical, emotional and social
function, attitudes to illness, patients' daily lives-includ-
ing family interactions, Spitzer, Dobson, et al. [1], Cella
and Tulsky [2].
Treatments that are designed to control symptoms are
suited for Quality of Life end points. When the goal of
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treatment is symptom palliation rather than prolonga-
tion, the use of Quality of Life as a primary end point of
survival can be considered, Winer [3]. As a result of the in-
creased interest in the impact of disease and treatment on
the patient's life and functioning, several well-validated
questionnaires that measure health-related quality of life
(HRQoL) have been developed, some of which formed
the foundation for the questionnaire that was used in this
study [4][5][6][7].
Cancer is not a disease of an individual but impacts the
family system. Families must confront, and attempt to re-
alize the meaning of cancer for the patient, for each family
member individually and for the family system as a whole
[8]. The diagnosis of cancer confronts both the patient
and his/her caregiver(s) with a major life crisis, therefore
family therapists now refer to the 'cancer family' and not
to the 'cancer personality' [9]. Furthermore, as a life-
threatening disease progresses, family members may as-
sume new roles and responsibilities. They are usually sup-
portive or concerned for their terminally ill patients, but
they are frequently opposed to the patient's wishes or the
recommendations of the treatment team. When the pa-
tient is incompetent, conflicts of interest may arise since
decision-making is a great responsibility for the family
[10]. A relative, who feels guilty or denies the hopeless-
ness of the situation, may press the patient for cure rather
than care, or to prolong or discontinue treatment [11].
It is worth noting, that every patient and family has a cul-
ture. Cultural aspects of values and behaviors are the key
variables, along with life experiences, socio-economic sta-
tus, and personality differences, that affect the meaning of
cancer for both individuals and their families, as well as
how they cope with the disease [10][12][13]. Thus, it is
important to mention the close bonds found in a Greek
family, especially towards severe problems such as cancer
[14]. Furthermore, when relatives know the truth and try
to keep it from their patients, they are likely to transmit
their fears and anxiety through non-verbal ways. The cost
of deception is high. For the patient who suspects but still
hopes, the state of uncertainty is harder to bear than the
certainty of the knowledge [15][16]. This attitude of non-
disclosure is not only associated with Greek culture but
has also been observed in Japan [17][18][19]. Denying ac-
ceptance of the disease, family members even avoid dis-
cussing about cancer [20][21].
The objectives of this study were to investigate the atti-
tudes, perceptions and patterns of choice in the manage-
ment of terminal stage cancer patients with respect to their
families through the development of a relatives' patient
management questionnaire. Typically HRQoL question-
naires assessing the patients' perceptions and choices are
used to determine choice of treatment and palliation,
however, with the realization that cancer families are also
affected and involved by the disease and its management
their perceptions of management choices are becoming
important considerations in oncology.
Methods
The study took place in the Pain Relief and Palliative Care
Unit, of Areteion Hospital, in University of Athens. The
study was carried out between March and September
2000, with hospital ethics committee approval. During
this time 400 relatives of advanced cancer patients visited
the Unit, from all over Greece. The questionnaire was ran-
domly distributed to 146 Greek relatives who approached
the Unit for pain relief and the control of other cancer re-
lated symptoms. It was drawn using stratified random
sampling, based upon the level of first-degree relatedness,
i.e. spouse, child, sibling, parent.
Inclusion criteria were a) first-degree relative, b) mentally
capable, c) informed consent.
The relatives were asked to complete the questionnaire in
the outpatient unit, and were given brief instructions on
how to complete the questionnaire (particularly Question
3). The initial measurement consisted of 25-item ques-
tions, composed of 6 multi-item scales, and 7 single item
scales. Twelve of the scales were presented into 3 optional
statements to be scored "yes", "sometimes", "no", and the
relatives were asked to mark the appropriate answer ac-
cordingly. Question number 3 consisted of 7 factors and
relatives had to mark their choice in a hierarchical order.
The questionnaire was designed to be self-assessment and
was formulated after a thorough review of the relevant lit-
erature, incorporating previously validated questions
from other scales and measures appropriate for use in pal-
liative care settings for the assessment of relatives' patient
management perceptions and choices [4][5][6][7]. The
questionnaire contained 4 sections with different aspects
of consultation: information disclosure (Qs, 1, 2, 4, 8);
therapy choices (Q 3); support-communication and care
(Qs, 5, 6, 7, 9 and 13) and hospitalization (Qs, 10, 11,
12). Patients' medical records provided information
about demographics and disease characteristics, specifi-
cally: type of cancer, presence of metastasis, and Karnof-
sky performance. Similar demographic data was obtained
from the relatives: age and sex, with stratification based
upon degree of relatedness, spouse, child, parent, sibling;
educational status, primary, high school and university;
residence, rural, village and town. Multivariate analysis
was conducted on these stratifications. However, no anal-
ysis was conducted for the stratification residence, as only
10 relatives did not reside in the town. Relatives were also
timed during the completion of the questionnaire.BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/3
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Quantitative variables are described by the mean ± stand-
ard deviation. Quantitative aspects were analyzed using t-
test, one-way and two-way analysis of variance (ANOVA)
and categorical variables by Pearson's chi-square, where
appropriate. The reliability and validity was assessed by
average inter-item and average item totals and Cronbach's
alpha. Statistical significance was accepted with p ≤  0.05.
Results
The patients' survival time was between 4 months to 5
years (median: 2 years) while they were off anti-cancer
treatment and under palliative care for symptom control.
Socio-demographic and clinical data for patients and rel-
atives are presented in Table 1. In all the questions, except
for question number 3, the rate of answers given was
100%, the average time required to complete the ques-
tionnaire was 8–10 minutes. Regarding question number
3, 15% of responders did not complete this question.
Descriptive statistics for the questionnaire are presented in
Table 2, for all questions except question 3. Some points
of interest that derive from Table 2 include the following.
First, a small percentage (23%) of relatives believe that di-
agnosis and prognosis should be revealed to the patients,
while the majority (56% and 51% respectively) of the par-
ticipants believe that only "sometimes" they would agree
to do so. However, they are of the opinion that the pa-
tients should be given information on the possible treat-
ment choices (71%) and the complications or side effects
of the treatment (53%). A large percentage (81.5%)
would like a health care team to be involved in caring for
their patients, and 76% would like physicians from vari-
ous specialties to co-operate, when this is judged neces-
sary, and 78% of relatives would like the assistance of a
social worker. However, only 44% would choose psycho-
logical support from specialists, even though 34% an-
swered that they "sometimes" prefer the cooperation with
psychologists. Several family members (67%), indicated
that they would prefer to inform their patients of the pal-
liative nature of the treatment, but only 44% would dis-
cuss with them their fears on death, with 28%
"sometimes" choosing to discuss about it and 28% not.
Only 30% chose the intensive care unit for a patient in the
terminal stage, while 57% preferred the patients to stay at
home with the provision of the appropriate care. It is
worth mentioning that close communication and support
are variables, which are now starting to be considered se-
riously from the vast majority of the relatives (96%).
The results of question number 3 "choice of the medical
treatment" are presented in Table 3 (the distribution of
factors influencing choice of treatment in a hierarchical
order), and the percentage first choice for each of the
items is depicted in Figure 1. According to the partici-
pants, the first choice on the hierarchy is the factor " ex-
pectance of survival" (28%), while only an 18.5% chose
the factor of "long term quality of life" as first in the hier-
archy. The most common second factor is "expected effec-
tiveness" (28%). The "long-term quality of life", depicts
third place (19%), while 18.5% chose the factor of "ex-
pected effectiveness". The patients' "short-term quality of
life" comes forth in the hierarchy (21%), while the factor
of "possible complications and side effects" comes fifth
(20.5%). The latter, also occupies the sixth place in the hi-
erarchical ranking (23%). As the most common lowest
ranked factor was, "consequences in the patients' sexuali-
ty" (63%).
Reliability of the three different aspects of consultation:
information disclosure (Qs, 1, 2, 4, 8), support-communi-
cation and care (Qs, 5, 6, 7, 9 and 13) and hospitalisation
(Qs, 10, 11, 12) (scales) were assessed by average inter-
item correlation, average item total correlation and Cron-
bach's alpha. This initial analysis prompted shortening of
the questionnaire via the removal of questions 6 and 13
from the support-communication and care group, and
question 12 from the hospitalisation group. This shorten-
ing of the questionnaire resulted in improving the average
all item total and inter-item correlations to between 0.62–
0.70. The internal-consistency reliability coefficients,
Cronbach's alpha correlations, for the three scales were:
Table 1: Socio-demographic characteristics
Relatives' Age 
(mean, ± s.d)
Range
48 ± 15 19–80
N%
Sex Male 39 27
Female 107 73
Education Primary 22 15
High School 73 50
University 51 35
Patients' Sex Male 88 60
Female 58 40
Patients' Age 
(mean, ± s.d)
Range
67 ± 12 30–98
N%
Cancer Locations Lung 38 27
Pancreatic 18 12
Rectum 15 10
Bladder 14 10
Other 61 42BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/3
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information disclosure (Qs, 1, 2, 4, 8) 0.66, support-com-
munication and care (Qs, 5, 6 and 7) 0.69 and hospitali-
sation (Qs, 10 and 11) 0.50. Using these shortened scales
the construct validity revealed that the items were sensibly
related to the domains that contained them (convergent
validity correlations between 0.6–0.86) and had no asso-
ciation with items from different domains (discriminate
validity). This reappraisal of the questionnaire has result-
ed in the generation of a 21-item scale consisting of 5 mul-
ti-item and 5 single-item scales, which demonstrates
acceptable validity in assessing relatives' perceptions and
choices for the palliative management of terminal stage
cancer patients.
Multivariate analysis of the socio-demographic data was
conducted for all remaining scales. For question 3, higher
scores were placed on all factors except "patient's long
term quality of life" ranked in the order University > High
School > Primary (0.001 > p > 0.02, ANOVA). A similar
trend, Child > Spouse, was observed for relatedness (as
only one relative was a parent and 9 were siblings theses
were not included in the analysis) with significance
reached in "consequences in patients sexuality", "the pa-
tients choice" and "patient's short term quality of life" (p=
0.007, 0.003 and 0.009, respectively; t-test).
With respect to relatedness, statistical significantly more
child than spouse favored "yes" to questions 1b) "for the
prognosis of the disease", 2b) "for the percentage of effec-
tiveness", 4) "amputative/disfiguring operations" and 5b)
"physicians from various specialties" (p = 0.001, 0.036,
0.06 and 0.05 respectively, chi-square). Stratification in
Table 2: Relatives' attitudes towards their patients' quality of life
Questionnaire items Percentage (%) of Relatives'
Responding 'yes' n 'sometimes' n 'no' n
1) Do you believe that patient should fully be informed
a) for the diagnosis? 23% 34 56% 82 20.5% 30
b) for the prognosis of the disease? 23% 34 51% 74 26% 38
2) Do you agree the patient to be informed
a) for the possible treatment choices? 71% 104 24% 35 5% 7
b) for the percentage effectiveness? 51% 74 37% 54 12% 18
c) for the complications or the side-effects of the 
treatment?
53% 77 33% 48 15% 21
4) Do you believe that patient should be informed before 
amputative/disfiguring operations?
68.5% 100 21% 31 10% 15
5) Would you like for the caring and treatment of cancer 
patients to be involved
a) the health care team? 81.5% 119 16% 24 2.% 3
b) physicians from various specialties Cooperating as 
necessary?
76% 111 12% 17 12% 18
6) Would you like to cooperate with psychological sup-
port specialists?
44% 64 34% 50 22% 32
7) Would you like to cooperate with a social worker? 78% 114 19% 28 3% 4
8) In the final stage of the patient would you prefer to 
inform him/her for the palliative nature of the treatment?
67% 98 24% 35 9% 13
9) Would you like to discuss with the patient his/her 
fears on death?
44% 64 28% 41 28% 41
10) In order to prolong the life of cancer patient for a 
few days in the final stage, would you choose the inten-
sive care unit?
30% 44 1 30% 44 39% 58
11) Do you believe that the advanced cancer patient 
when he/she receives the appropriate care should:
a) be hospitalized 32% 47 30% 44 38% 55
b) remain at home 57% 83 23% 34 20% 29
12) According to your opinion, the dying patient should:
a) remain at hospital? 34% 50 34% 50 31.5* 46
b) die at home? 41% 60 29% 42 30% 44
13) In order to prolong the life of cancer patient for a 
few days in the final stage, is communication and support 
from the relatives and friends important?
96% 140 4% 6 0 0BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/3
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relation to the sex of the relative demonstrated signifi-
cance towards men answering "yes" to Ib) "for the prog-
nosis of the disease", 10) "final stage.... intensive care
unit" and 11b) "remain at home" (p = 0.012, 0.016 and
0.048 respectively). For women answering "yes" 2a) "for
possible treatment choices" and 4) "amputative/disfigur-
ing operations" (p = 0.037 and 0.010 respectively). As for
educational status there was a clearly more pronounced
firm "yes" to various questions with higher educational
status (University > High school > Primary) for questions
2c) " complications or side-effects of the treatment", 4)
"amputative/disfiguring operations", 5a) "the health care
team", 5b) "physicians from various specialties", 7) "co-
operate with social worker", 8) "inform him/her for the
palliative nature of the treatment", 11b) "remain at
home" (p = 0.028, 0.001, 0.017, 0.018, 0.024, 0.007 and
0.002 respectively); however the reverse rank order (Uni-
versity < High school < Primary) was observed for 10) "fi-
nal stage....intensive care unit" and 11a) "be hospitalized"
(p = 0.001).
Discussion
Traditionally, studies concerning cancer have focused on
the effects of diagnosis, prognosis, treatment or the course
of the disease on patients' well-being which refers to psy-
chological as well as social and physical well-being, com-
ponents referred to as quality of life, Bloom [22], Lewis
and Bloom [23], Meyerowitz [24], Penman, Bloom et al
[25]. Most clinicians recognize that cancer is painful for
patients and their families, but surprisingly there is little
research to document this effect. Most of the studies in
this area examine the quality of life according to patient
assessments, Covinsky, Goldman et al [26].
In this article the assessment and validation of a question-
naire designed to assess terminal stage cancer patient fam-
ily perceptions and choices in patient management
(information disclosure, therapy choices, hospitalization,
support-communication and care) including aspects re-
garding end-of-life and quality-of-life decisions are pre-
sented. The goals of palliative treatment are to improve
patients' functioning and their quality of life [15], input
from relatives may offer additional measures in this re-
spect.
The questionnaire was well accepted by all the relatives
that approached the unit. On average, it required 8–10
minutes to complete, and relatives appeared to be pleased
that they could have the opportunity to participate in a
study examining their patients' quality of life. Following
completion of the survey, the reliability and validity of the
questionnaire was assessed by average inter-item and av-
erage item totals and Cronbach's alpha. Re-appraisal of
both the support-communication and care and the hospi-
talization sections indicated that by shortening the initial
25-item scale to a 21-item scale generated a questionnaire
that demonstrates acceptable validity and reliability.
In assessing the benefits of the treatment of a fatal illness,
health care professionals need to know about the quality
of survival. Withholding the truth from a patient appears
common in Greece [27], as reported in other nations Nii-
Figure 1
First choices from each factor in "choice of the medical treatment".BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/3
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mi [17], [18][19]; with more information given in the
U.S.A and U.K [28][29]. Many studies suggest that most
patients would like to be informed about the diagnosis
and prognosis of their disease [30], and evidence suggests
that there is little benefit in withholding such disclosure
[17][18][31]. Frequently, it seems that the caregivers take
all the responsibilities or even decide on the patient's be-
half, and the suffering person remains in ignorance [32].
This is apparent in the present study, where the percentage
of the relatives choosing the disclosure of diagnosis or
prognosis to their patients is small (23%, and 23% respec-
tively). However, a large percentage (56%) of the relatives
believe that only sometimes the diagnosis should be re-
vealed, while 51% indicated that only sometimes the
prognosis should be announced.
Multivariate analysis demonstrated that there was a signif-
icant trend (p = 0.001) for children of patients over
spouse in disclosure of "prognosis of disease". A similar
trend was observed with male relatives over females (p =
0.012). Furthermore, a trend towards a higher educational
status also favored this response (however, this was not
significant, p = 0.065), and that for patients' with cancer
devoid of metastasis there was also a significant trend to-
wards disclose (p = 0.028). This was similarly matched by
the response to question 3 "patients long term quality of
life", where only in stratification towards patients with
cancer (and not metastasis, p = 0.28) was there a signifi-
cantly greater interest for hierachical importance. In this
respect "expectance of survival" (p = 0.008), disclosure "of
the prognosis of disease" (p = 0.028) and "the involve-
ment of physicians from various specialties cooperating as
necessary" (p = 0.016) all added support to relatives' inter-
est and involvement in the decision making process
aimed at cure in non-metastatic patients.
Despite the fact that they confront such a dilemma, they
are still fairly certain as to their opinion with other aspects
such as their attitudes about informing their patients for
the possible treatment choices (71%) and for amputative/
disfiguring operations (68.5%). Additionally, 53% of the
relatives would choose the patient to be aware of the com-
plications or the side effects of the treatment. Again with
these latter two aspects there was a statistically significant
trend towards relatives with a higher educational status
indicating favorably (p = 0.001 and 0.028 respectively).
Still, although in most European countries doctors tend to
reveal the truth directly to the patient [27][28][29] with-
out the family's consent, it is still not common practice yet
in Greece, possibly as a result of the strong family bonds.
The health care team-patient relationship is a triangle not
a dyad, consisting of the health care professionals, the pa-
tient and the family. Each part supports the relationship
between the other two, and each is affected by what else
happens in the triangle [8][33]. Hence, the involvement
of health care teams is very important for the care and
treatment of the patients. A high percentage (81.5%) of re-
sponders indicated "yes", especially the higher educated
(p = 0.017), and a high percentage of relatives preferred to
cooperate with a social worker (78%, again correlating
with the more higher educated (p = 0.024)). The response
to the involvement of a psychologist (44%), however, was
somewhat contradictory, although only 22% were against
it. Cancer affects the family in many ways and it is impor-
tant for them to have effective co-operation with health
care professionals in order to receive care. In the final
stage, 67% of family members would prefer to inform pa-
tients about the palliative nature of the treatment (p =
0.07 for the higher educated). This is probably due to the
fact that the relatives try to preserve the patients' quality of
life until their death.
Ongoing open communication between cancer patients
and family members is essential, both between each other
and with health care professionals. Patients and family
Table 3: Ranking variables of treatment choices
Expectance of 
survival
Expected 
Effectiveness
Complications 
Side-effects
Consequences 
in sexuality
Patient's 
Choice
Short term 
QoL
Long term 
QoL
Choices
1st 41 (28%) 24(16%) 4 (3%) 0 18(12%) 8 (5.5%) 27(18.5%)
2nd 20 (14%) 41 (28%) 5 (3%) 0 11(7.5%) 20(13.5%) 27(18.5%)
3rd 20 (14%) 27(18.5%) 17(12%) 0 18(12%) 12 (8%) 28 (19%)
4th 23 (16%) 12 (8%) 26(18%) 4 (3%) 17(11.5%) 31 (21%) 11(7.5%)
5th 5 (3%) 17(11.5%) 30 (20.5%) 2 (1%) 24(16%) 28(19%) 17(11.5%)
6th 12 (8%) 2 (1%) 34 (23%) 26(18%) 28(19%) 14 (9.5%) 7 (5%)
7th 3 (2%) 0 6 (4%) 92 (63%) 8 (5.5%) 11 (7.5%) 4 (3%)
missing 22 (15%) 22(15%) 22(15%) 22 (15%) 22(15%) 22(15%) 22(15%)BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/3
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members need to feel supported in their expressions. The
health care team can help by letting family members
know that emotional stress and behavioral changes are
not uncommon during illness, that these and other prob-
lems can be overcome with patience and support [22]. It
is undoubtedly true, that social support can help people
to cope with the psychological effects of cancer and help
promote physical recovery; when this support is not avail-
able or is withheld the patients' situation is aggravated
[34]. The aspect that arises from the study is the fact that
the vast majority of the caregivers give a special emphasis
on communication between patients and the social envi-
ronment (family, friends), and the support they receive
with respect to disclosure of treatment choices, the in-
volvement of health care teams, cooperation with social
workers and physicians from various specialties, all of
which demonstrated a stronger positive correlation with a
higher educational status. Such communication provides
support to the family – between health care professionals,
patients and relatives – and the means to overcome the di-
lemma between disclosing information to the patient on
prognosis, diagnosis and the treatment choice.
Conclusions
The study argues that more attention needs to be paid to
family members of cancer patients, as they are the primary
caregivers in order to have more open-communication
with their patients, and to be more empathic and realize
the welfare of their patients' quality of life. Good family
interactions can help cancer patients adjust to diagnosis
and treatment. Family relationships appear to be particu-
larly important because the family is involved with the pa-
tient during the illness. The dynamics of family
interactions can set the stage of social interactions with
friends and health care providers. After all, cancer is a fam-
ily illness and disrupts the relationship between them and
the health care team.
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